These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 36064712)

  • 1. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H; Han Y; Cao C; He Y
    J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
    Wang R; Dai L; Zhong Y; Xie G
    Lipids Health Dis; 2021 Jul; 20(1):77. PubMed ID: 34321005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Zhang F; Han Y; Wu Y; Bao Z; Zheng G; Liu J; Li W
    Ann Med; 2024 Dec; 56(1):2409342. PubMed ID: 39348274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease].
    Xiao J; Li Y; Fang M; Gong H; Li W; Zhang C; Chen F; Zhang Y; Han T
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1266-1271. PubMed ID: 39051072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
    Kilonzo SB; Kamala E; Jaka H; Ngoya P
    BMC Gastroenterol; 2024 Mar; 24(1):96. PubMed ID: 38438930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
    BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
    Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
    Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
    Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
    Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease.
    Wang M; Chang M; Shen P; Wei W; Li H; Shen G
    Lipids Health Dis; 2023 Nov; 22(1):186. PubMed ID: 37924128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease.
    Kim B; Jin HY; Yoon JS; Noh ES; Hwang IT
    J Clin Res Pediatr Endocrinol; 2024 Sep; 16(3):306-313. PubMed ID: 38664989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.
    Chen Q; Hu P; Hou X; Sun Y; Jiao M; Peng L; Dai Z; Yin X; Liu R; Li Y; Zhu C
    Cardiovasc Diabetol; 2024 Jul; 23(1):232. PubMed ID: 38965572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.